# Westamerica Bancorporation: overview

WABC · Nasdaq · CIK 311094 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wabc.md) · [Financials](/companies/wabc/financials.md) · [Filings](/companies/wabc/filings.md) · [Insiders](/companies/wabc/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [1.31](/filings/0001171843-25-007134.md) | not reported | [1.16](/filings/0001171843-26-003210.md) | [1.12](/filings/0001171843-26-005234.md) | [1.12](/filings/0001171843-25-007134.md) | not reported | [1.13](/filings/0001171843-26-003210.md) | [1.17](/filings/0001171843-26-005234.md) |
| Free cash flow | $m | [40.1 d](/filings/0001171843-25-007134.md) | [29.1 d](/filings/0001171843-26-001195.md) | [42.2](/filings/0001171843-26-003210.md) | [22.8 d](/filings/0001171843-26-005234.md) | [28.7 d](/filings/0001171843-25-007134.md) | [25.9 d](/filings/0001171843-26-001195.md) | [38.7](/filings/0001171843-26-003210.md) | [15.2 d](/filings/0001171843-26-005234.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [3.22](/filings/0001171843-24-001054.md) | [4.54](/filings/0001171843-25-001156.md) | [6.06](/filings/0001171843-26-001195.md) | [5.20](/filings/0001171843-26-001195.md) | [4.52](/filings/0001171843-26-001195.md) |
| Free cash flow | $m | [87.4](/filings/0001171843-24-001054.md) | [113](/filings/0001171843-25-001156.md) | [157](/filings/0001171843-26-001195.md) | [140](/filings/0001171843-26-001195.md) | [120](/filings/0001171843-26-001195.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/wabc/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $195.7m | 3,335,703 |  | Reduced −113,632 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $114.9m | 1,958,072 |  | Added +51,202 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $101.0m | 1,720,645 |  | Reduced −38,905 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $81.8m | 1,394,074 |  | Added +190,791 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $60.7m | 1,034,531 |  | Reduced −60,547 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $57.7m | 983,639 |  | Added +38,940 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $36.8m | 627,073 |  | Added +13,911 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $29.1m | 495,223 |  | Added +96,177 |
| [Nuveen, LLC](/funds/1871926.md) | 2026-06-30 | $22.4m | 382,288 |  | Added +22,943 |
| [Rhino Investment Partners, Inc](/funds/1828776.md) | 2026-06-30 | $19.1m | 324,824 |  | New +324,824 |

## Recent filings

[All 806 filings](/companies/wabc/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 13:11 ET | [8-K](/filings/0001171843-26-006773.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-006773 |
| 2026-10-15 | 13:27 ET | [8-K](/filings/0001171843-26-006660.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-006660 |
| 2026-08-05 | 14:43 ET | [10-Q](/filings/0001171843-26-005234.md) | Quarterly report, period 2026-06-30 | 0001171843-26-005234 |
| 2026-07-23 | 13:15 ET | [8-K](/filings/0001171843-26-004853.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-004853 |
| 2026-07-16 | 13:47 ET | [8-K](/filings/0001171843-26-004727.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-004727 |
| 2026-05-08 | 13:53 ET | [10-Q](/filings/0001171843-26-003210.md) | Quarterly report, period 2026-03-31 | 0001171843-26-003210 |
| 2026-04-27 | 17:25 ET | [8-K](/filings/0001171843-26-002737.md) | 5.07 Shareholder vote results | 0001171843-26-002737 |
| 2026-04-24 | 17:16 ET | [8-K](/filings/0001171843-26-002706.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-002706 |
| 2026-04-23 | 14:17 ET | [8-K](/filings/0001171843-26-002678.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-002678 |
| 2026-04-16 | 14:02 ET | [8-K](/filings/0001171843-26-002511.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-002511 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001171843-26-001195.md), filed Feb 27, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 311094
- Tickers: WABC
- Exchange: Nasdaq
- SIC code: 6021 National Commercial Banks
- State of incorporation: CA
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 12:41 ET. No prices; not investment advice.